IL10 and type 2 diabetes mellitus: However, numerous studies have shown that type 2 diabetes impairs B-cell function and the accumulation of antibodies, mainly in the form of impaired responsiveness toward viral infection, an enhanced production of pro-inflammatory IL-8, and a failure to secrete anti-inflammatory IL-10, all of which are highly associated with inflammatory disease resolution [86,87].